Bora Pharmaceuticals Co., LTD. (TPE: 6472)

Market Cap	81.74B
Revenue (ttm)	16.71B
Net Income (ttm)	3.90B
Shares Out	103.34M
EPS (ttm)	37.12
PE Ratio	21.31
Forward PE	16.90
Dividend	12.00 (1.53%)
Ex-Dividend Date	Aug 12, 2024

Volume	700,365
Average Volume	1,003,936
Open	788.00
Previous Close	782.00
Day's Range	769.00 - 793.00
52-Week Range	612.00 - 975.00
Beta	0.75
RSI	56.33
Earnings Date	Mar 7, 2025

About Bora Pharmaceuticals Co., LTD.

Bora Pharmaceuticals Co., LTD. researches and develops, manufactures, distributes, and sells pharmaceuticals worldwide. The company operates through Sales, Contract Development & Manufacturing Organization, and Other segments. It manufactures and sells generic, brand, and over the counter (OTC) drugs. The company also offers contract development and manufacturing services, including clinical and commercial manufacturing, pharmaceutical development, packaging and serialization, analytical and microbiology testing, and regulatory affairs services...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2007
• Country: Taiwan
• Stock Exchange: Taiwan Stock Exchange
• Ticker Symbol: 6472

Financial Performance

In 2023, Bora Pharmaceuticals Co., LTD.'s revenue was 14.20 billion, an increase of 35.31% compared to the previous year's 10.49 billion. Earnings were 3.03 billion, an increase of 117.70%.